Development of potential proteasome inhibitors against Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of potential proteasome inhibitors against Mycobacterium tuberculosis

Published:2020-10-19 Issue: Volume: Page:1-15
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Tyagi Rashmi¹,Srivastava Mitul²,Jain Preeti³,Pandey Ramendra Pati¹,Asthana Shailendra²,Kumar Dhruv⁴,Raj V. Samuel¹

Affiliation:

1. Centre for Drug Design Discovery and Development (C4D), SRM University, Delhi, Haryana, India

2. Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad, India

3. Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India

4. Amity Institute of Molecular Medicine and Stem Cell Research, Amity University Uttar Pradesh, Noida, India

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1835722

Reference38 articles.

1. The transpeptidase PbpA and noncanonical transglycosylase RodA of Mycobacterium tuberculosis play important roles in regulating bacterial cell lengths

2. TheMycobacterium tuberculosisPup-proteasome system regulates nitrate metabolism through an essential protein quality control pathway

3. Proteasomal Protein Degradation in Mycobacteria Is Dependent upon a Prokaryotic Ubiquitin-like Protein

4. Small-Molecule Library Screening by Docking with PyRx

5. The Proteasome of Mycobacterium tuberculosis Is Required for Resistance to Nitric Oxide

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive computational and pharmacokinetic investigation of an amide derivative (C34H34N8O4S2) as a potential drug candidate for tuberculosis: Unraveling structural analysis and reactivity descriptors;Journal of the Indian Chemical Society;2024-09

2. Crystallographic mining driven computer-guided approach to identify the ASK1 inhibitor likely to perturb the catalytic region;Journal of Biomolecular Structure and Dynamics;2023-12-09

3. Mycobacterium tuberculosis: Pathogenesis and therapeutic targets;MedComm;2023-09-04

4. Nanobiotics and the One Health Approach: Boosting the Fight against Antimicrobial Resistance at the Nanoscale;Biomolecules;2023-07-28

5. Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells;Frontiers in Oncology;2023-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3